Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome.
VIOT, Benjamin
CHU de Bordeaux Pellegrin [Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
Voir plus >
CHU de Bordeaux Pellegrin [Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
VIOT, Benjamin
CHU de Bordeaux Pellegrin [Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
CHU de Bordeaux Pellegrin [Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
BACHELET, Thomas
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
MOREAU, Jean-Francois
Composantes innées de la réponse immunitaire et différenciation [CIRID]
Service d'immunologie et d'immunogénétique [Bordeaux]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
Composantes innées de la réponse immunitaire et différenciation [CIRID]
Service d'immunologie et d'immunogénétique [Bordeaux]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
DECHANET-MERVILLE, Julie
Composantes innées de la réponse immunitaire et différenciation [CIRID]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
Composantes innées de la réponse immunitaire et différenciation [CIRID]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
MERVILLE, Pierre
Composantes innées de la réponse immunitaire et différenciation [CIRID]
CHU de Bordeaux Pellegrin [Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
Composantes innées de la réponse immunitaire et différenciation [CIRID]
CHU de Bordeaux Pellegrin [Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
COUZI, Lionel
Composantes innées de la réponse immunitaire et différenciation [CIRID]
CHU de Bordeaux Pellegrin [Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
< Réduire
Composantes innées de la réponse immunitaire et différenciation [CIRID]
CHU de Bordeaux Pellegrin [Bordeaux]
Service de Néphrologie-transplantation-dialyse [Bordeaux]
Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
Langue
EN
Article de revue
Ce document a été publié dans
Transplant Infectious Disease. 2015-08-01, vol. 17, n° 4, p. 497-509
Résumé en anglais
The incidence and the impact of asymptomatic cytomegalovirus (CMV) DNAemia occurring after the first year post transplantation is unknown. In this retrospective cross-sectional study, we analyzed the incidence, risk factors, ...Lire la suite >
The incidence and the impact of asymptomatic cytomegalovirus (CMV) DNAemia occurring after the first year post transplantation is unknown. In this retrospective cross-sectional study, we analyzed the incidence, risk factors, and impact of 2-year post-transplantation asymptomatic CMV DNAemia (2YCD) on graft function. We included 892 consecutive asymptomatic kidney transplant recipients transplanted for at least 2 years and all were monitored using whole blood CMV quantitative nucleic acid amplification testing (CMV-QNAT). Twenty-eight patients displayed 2YCD (3.1%). Using multivariate analysis in 578 patients, we found that female gender (odds ratio [OR] = 2.57, P = 0.02), a past history of CMV drug-resistance mutation (OR = 8.73, P = 0.005), and corticosteroid use (OR = 2.37, P = 0.03) were independently associated with an increased risk of 2YCD. 2YCD was associated with an increased incidence of subsequent CMV disease over the year following its diagnosis (7% vs. 0.6%, P = 0.02). Patients with 2YCD also exhibited a declining estimated glomerular filtration rate more frequently (77%) than patients with a negative CMV-QNAT (56%, P = 0.02). 2YCD appears to be a rare entity, which appears to be associated with chronic graft dysfunction.< Réduire
Mots clés en anglais
Aged
Asymptomatic Infections
Cross-Sectional Studies
Cytomegalovirus
Cytomegalovirus Infections
Female
Follow-Up Studies
Graft Survival
Humans
Incidence
Kidney Transplantation
Logistic Models
Male
Middle Aged
Outcome Assessment
Health Care
Postoperative Complications
Retrospective Studies
Risk Factors
Sex Factors
Unités de recherche